<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53997">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02403206</url>
  </required_header>
  <id_info>
    <org_study_id>CTW860-P001</org_study_id>
    <nct_id>NCT02403206</nct_id>
  </id_info>
  <brief_title>Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts</brief_title>
  <official_title>Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon, a Novartis Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare femtosecond laser-assisted capsulotomy to manual
      capsulorhexis in patients with intumescent cataracts. An intumescent cataract is defined as
      a cataract with a pressurized capsular bag.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 26, 2015</start_date>
  <completion_date type="Actual">August 24, 2016</completion_date>
  <primary_completion_date type="Actual">July 12, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of capsular tears (anterior or posterior) during surgery</measure>
    <time_frame>Day 0 (operative day)</time_frame>
    <description>A capsular tear is any unintended tear on the anterior or posterior capsule and includes a radial tear that moves peripherally on the anterior capsule during capsulotomy and extends to form a posterior capsular tear.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operating time in the eye to complete entire cataract procedure</measure>
    <time_frame>Day 0 (operative day)</time_frame>
    <description>Operating time in the eye is the time interval from the time the corneal incision is opened to the time the wound is closed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">406</enrollment>
  <condition>Intumescent Cataract</condition>
  <arm_group>
    <arm_group_label>Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Femtosecond laser assisted capsulotomy and corneal incision performed during cataract surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous curvilinear capsulorhexis performed during cataract surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond laser</intervention_name>
    <description>Laser console and a patient interface used to cut tissue during cataract removal of the crystalline lens</description>
    <arm_group_label>Laser</arm_group_label>
    <other_name>LenSxÂ® Laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous Curvilinear Capsulorhexis</intervention_name>
    <description>Standard-of care manual procedure (using either needles or forceps) for creating capsulorhexis, ie., opening in capsular bag during anterior segment ophthalmic surgery</description>
    <arm_group_label>Manual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing to undergo cataract surgery.

          -  Able to lie flat in a supine position.

          -  Able to understand and willing to sign the Informed Consent Form (ICF).

          -  Presenting with intumescent white cataract, with a liquid pressurized bag and a
             milky, liquid cortex.

          -  Other protocol-specified inclusion criteria may apply.

        Exclusion Criteria:

          -  Pregnant or lactating mothers.

          -  Corneal disease that precludes application of the cornea or transmission of laser
             light at 1030 nanometer (nm) wavelength.

          -  Corneal opacity that would interfere with the laser beam.

          -  Presence of blood or other material in the anterior chamber.

          -  Hypotony or presence of corneal implant.

          -  Poorly dilating pupils.

          -  Condition which would cause inadequate clearance between the intended capsulotomy
             depth and the endothelium.

          -  Residual, recurrent, active ocular or eye lid disease, including any corneal
             abnormality.

          -  Any contraindication to cataract surgery.

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Manager, Surgical</last_name>
    <role>Study Director</role>
    <affiliation>Alcon, A Novartis Division</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 27, 2017</lastchanged_date>
  <firstreceived_date>March 26, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
